title: [Contraceptive methods after gynecological and breast cancer].
abstract: With earlier diagnosis and more effective treatments, more and more women are receiving fertility-preserving cancer therapy. Approximately 10% of breast and gynecological cancers occur in women under 40, and more than 5 000 French women under 45 develop breast cancer each year. While hormonal contraception is contra-indicated for women with a history of breast or endometrial cancer, it seems to have a protective effective in ovarian cancer. Although pregnancy is not contra-indicated after cancer, it must be planned in a timely manner, meaning that appropriate contraception is necessary in the meantime.
authors.affiliation: Académie nationale de médecine. bernard-jl.blanc@nerim.net
authors.forename: Bernard
authors.initials: B
authors.lastname: Blanc
authors.forename: Alexandre
authors.initials: A
authors.lastname: Lazard
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Estrade
authors.forename: Aubert
authors.initials: A
authors.lastname: Agostini
authors.forename: Brice
authors.initials: B
authors.lastname: Gurriet
mesh_terms: D001943:Breast Neoplasms / Q000150:complications* / Q000628:therapy; D003267:Contraception; D003278:Contraceptives, Oral, Hormonal; D000075202:Contraindications; D005260:Female; D005833:Genital Neoplasms, Female / Q000150:complications* / Q000628:therapy; D006801:Humans; D011247:Pregnancy
chemical_list: D003278:Contraceptives, Oral, Hormonal